Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC459 for prevention or attenuation of rhinovirus-induced asthma worsening
2015-002555-10Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma and allergic asthma comparing OC459 with Placebo (2 arms). Primary endpoint: Total Lower Respiratory Tract Symptoms Score after rhinovirus infection. Started Sep 2015; status: completed.
02
Drugs
timapiprant
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on 2015-002555-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002555-10.